Evaluation of Ranibizumab for diabetes macular edema

Evaluation of Ranibizumab for diabetes macular edema - Evaluation of Ranibizumab for diabetes macular edema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001984

Enrollment

Registered

2010-10-01

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes macular edema

Interventions

Intravitreal injection of Ranibizumab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with diabetic macular edema.

Exclusion criteria

Exclusion criteria: Tha patients who has history of myocardial infarction and brain infarction.

Design outcomes

Primary

Measure	Time frame
retinal thickness, visual acuity	—

Countries

Japan

Contacts

Public ContactSakiko Nakano

Yamagata University faculty of medicine Department of ophthalmology

023-628-5374

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026